Search Tag: Radical-7
New Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
2020 20 Jul
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for newborns using Masimo SET® pulse oximetry.1 The authors concluded that “Our results encourage... Read more
Multicenter Study Evaluates Trend Accuracy of Three Hb Monitoring Methods, including Masimo SpHb
2019 09 Dec
Masimo announced today that in a multicenter study recently published in the Journal of Clinical Monitoring and Computing, researchers at three institutions – Loma Linda University in California (LLU), the University of California at Irvine (UCI), and Mayo Clinic in Jacksonville, Florida (MCF) – evaluated the trend accuracy of three hemoglobin (Hb)... Read more
Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring Platform
2017 02 Feb
Masimo announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential degree of patient deterioration. Root, which works in conjunction with Radical-7® or... Read more
France’s University Hospitals Adopts Masimo Radical-7®,Including SpHb®,PVI®,& SET® Pulse Oximetry
2016 21 Apr
Masimo (NASDAQ: MASI) has announced that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo’s Radical-7®, including noninvasive, continuous hemoglobin (SpHb®), Pleth Variability Index (PVI®), and SET® pulse oximetry technology, to monitor surgical patients and critical patients in the post-anesthesia care unit... Read more